| Categories |
Description |
Criteria |
Who can apply |
Excellence in Advanced Materials Packaging
|
Recognizes suppliers of packaging materials who have created innovations to enhance product protection, performance, or functionality in pharmaceutical packaging.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated` in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Pharmaceutical Companies with their registered office in India as on March 31, 2026
|
Excellence in Anti-Counterfeit Packaging
|
Recognizes pharmaceutical companies for implementing packaging solutions to protect products against counterfeiting, tampering, and unauthorized distribution.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated` in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Pharmaceutical Companies with their registered office in India as on March 31, 2026
|
Excellence in Automation & Machinery Packaging
|
Recognizes packaging machinery and automation service providers who have created innovations in equipment that enhance the speed, accuracy, safety, and operational efficiency of the solutions they deliver to Pharmaceutical clients.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated` in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Packaging machinery and automation solution providers registered in India as of March 31, 2026.
|
Excellence in Biologics
|
Recognizes pharmaceutical companies for implementing solutions designed to protect biologics, vaccines, and other temperature-sensitive products by maintaining required temperature conditions and ensuring product stability during storage and transport.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented or launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated` in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Pharmaceutical Companies with their registered office in India as on March 31, 2026
|
Excellence in Child-Resistant & Accessible Packaging
|
Recognizes pharmaceutical companies for implementing solutions designed to prevent unintended access by children while ensuring accessibility for seniors and individuals with limited strength, mobility, or vision.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Pharmaceutical Companies with their registered office in India as on March 31, 2026
|
Excellence in Drug Delivery Packaging
|
Recognizes pharmaceutical companies for implementing solutions to enhance the delivery, administration, or dosage accuracy of pharmaceutical products, with the objective of improving treatment outcomes and patient compliance.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated in relation to the initiative may have been launched prior to the eligibility period
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Pharmaceutical Companies with their registered office in India as on March 31, 2026
|
Excellence in Packaging Design
|
Excellence in Primary Packaging Design:
- Recognizes excellence in primary packaging design led or owned by pharma companies that ensures drug product protection, safety, integrity, and patient‑friendly use, while meeting regulatory and quality requirements.
Excellence in Secondary Packaging Design:
- Recognizes pharma company–driven secondary packaging design that enhances protection of the primary pack while delivering clear communication, tamper evidence, serialization readiness, and improved patient accessibility.
Excellence in Tertiary Packaging Design:
- Recognizes efficient and innovative tertiary packaging approaches led by pharma companies that safeguard products throughout the supply chain while optimizing logistics, cost, sustainability, and operational performance.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated` in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Pharmaceutical companies with a registered office in India as of March 31, 2026.
|
Excellence in Packaging R&D Collaboration
|
Recognizes collaborative research and development efforts between pharmaceutical companies and ecosystem partners that resulted in innovative pharmaceutical packaging solutions, technologies, or formats.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The R&D initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Mandatory collaboration requirement:
- This category is open only to collaborative R&D initiatives involving a pharmaceutical company and one or more ecosystem partners engaged in packaging materials, technology, design, engineering, testing, validation, or manufacturing.
- Collaborations involving more than one pharmaceutical company are also permitted, provided the initiative demonstrates clear relevance to pharmaceutical packaging R&D.
- Solo or single entity initiatives are not eligible.
- Concept-only proposals are not accepted.
|
Pharmaceutical companies and their ecosystem partners involved in collaborative packaging R&D initiatives, with at least one pharmaceutical company, registered in India as of March 31, 2026.
|
Excellence in Patient-Centric Packaging
|
Recognizes pharmaceutical companies for implementing solutions to improve usability, safety, and clarity for patients or healthcare providers.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024 to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Pharmaceutical Companies with their registered office in India as on March 31, 2026
|
Excellence in Supply Chain Innovation
|
Recognizes joint efforts that improve the efficiency of pharmaceutical packaging supply chains, logistics effectiveness, or packaging processes through collaboration between pharmaceutical companies and ecosystem partners like manufacturers, material suppliers, contract manufacturers, and others.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated` in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- This category is open only to joint projects executed between a pharmaceutical company and one or more ecosystem partners involved in pharmaceutical packaging, supply‑chain operations, logistics, materials, technology, or machinery.
- The pharmaceutical company may be either the Participating Entity (Lead Applicant) or a Collaborating Partner Entity.
- Solo or single entity initiatives are not eligible.
- Concept-only proposals are not accepted.
|
Pharmaceutical companies and their ecosystem partners involved in joint packaging supply chain initiatives, with at least one pharmaceutical company, registered in India as of March 31, 2026.
|
Excellence in Sustainable Pharma Packaging
|
Recognizes pharmaceutical companies that have successfully implemented packaging solutions that significantly reduce environmental impact.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Pharmaceutical Companies with their registered office in India as on March 31, 2026
|
Excellence in Traceability Systems
|
Recognizes pharmaceutical companies for implementing packaging technologies and digital systems to enable tracking and verification of products across the supply chain, ensuring transparency, compliance, and product security.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated` in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Pharmaceutical Companies with their registered office in India as on March 31, 2026
|
Excellence Pilot Innovation Award
|
Recognizes companies for early-stage packaging innovations that have been validated through pilots or trials, with entries invited from across the pharmaceutical packaging ecosystem.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The innovation must be early-stage and validated through at least one of the following:
- Pilot implementation
- Trial run
- Proof-of-concept testing
- Laboratory or simulated validation
- Controlled field evaluation
- The validation, pilot, or trial must have been conducted between April 01, 2024, and March 31, 2026.
- The innovation must demonstrate clear applicability or relevance to pharmaceutical packaging, even if not yet commercially deployed.
- Fully commercialized, mass-market solutions are not eligible for this category.
- Concept-only ideas without testing, validation, or trial results are not eligible.
|
Pharmaceutical companies / Startups / Institutes / Pharma R&D teams / Packaging technology firms, or their supply chain partners registered in India as of March 31, 2026.
|
Packaging Professional of the Year
|
Packaging professional - More than 10 Years of Experience:/div>
- Recognizes senior packaging professionals from pharma companies with over 10 years of experience including 1 years with the current organization, such as a Senior Packaging Engineer or Packaging Development Manager, or equivalent roles, who have demonstrated long‑term impact through innovation in packaging design, development, technology, operations, or sustainability.
Packaging professional - Upto 10 Years of Experience:
- Recognizes emerging or mid‑career professionals from pharma companies with up to 10 years of experience including 1 years with the current organization, such as a Packaging Engineer or Packaging Technologist, or equivalent roles, who have shown strong innovation, problem‑solving, and early leadership in packaging design, development, technology, or sustainability.
|
- The nominee must be an employee of a pharmaceutical company operating in India.
- The nominee must meet the experience requirement of the category applied for, as of March 31, 2026.
- The nominee must have completed at least one year of continuous service with the current organization.
|
Employees of pharmaceutical companies operating in India as of March 31, 2026.
|
